Skip to main content
Premium Trial:

Request an Annual Quote

Biotage Signs Australia, NZ Distribution Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swedish biomedical tools maker Biotage said today that it has tapped John Morris Scientific to distribute its products in Australia and New Zealand.

Biotage said that the agreement with JMS, which has 13 offices in Australia and New Zealand, will enable it to take advantage of increasing regional demand for its chromatography products, resins, and microwave systems for organic synthesis. The firm also makes sample prep systems.

Biotage Director of International Sales Vijay Gupta said in a statement that the firm expects the partnership "will result in excellent sales and service support for our customers in the region, as well as solid business growth."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.